Farid Benayoud

Farid Benayoud serves as Senior Director of Process Chemistry at Karyopharm Therapeutics Inc. since June 2022, following a role as Senior Principal Scientist in Process Development and Technical Operations at Cerevel Therapeutics from May 2021 to June 2022. Prior to these positions, Farid accumulated extensive experience at Eisai US, where roles included Principal Scientist in Precision Chemistry and Senior Scientist in various capacities, including Next Generation System and Process Development, from April 2001 to May 2021. Farid's academic background includes post-doctoral positions at the University of Wisconsin-Madison under Professor Steven D. Burke, focusing on the Total Synthesis of Halichondrin B, and at the University of Massachusetts Dartmouth under Professor Gerald B. Hammond, specializing in the Synthesis of α,β-unsaturated Fluorophosphonates.